Melatonin in the biliary tract and liver: Health implications

Current Pharmaceutical Design

Volumn 20, Issue 30, 2014, Pages 4788-4801

  Reiter, Russel J ^a   Rosales Corral, Sergio A ^a   Manchester, Lucien C ^a   Liu, Xiaoyan ^a   Tan, Dun Xian ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Antioxidant; Bile; Enterohepatic circulation; Free radicals; Liver; Melatonin

Indexed keywords

MELATONIN; MELATONIN DERIVATIVE; ANTIOXIDANT; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE;

ANTIOXIDANT ACTIVITY; ARTICLE; CEREBROSPINAL FLUID; ENTEROHEPATIC CIRCULATION; GASTROINTESTINAL TRACT; HEPATOBILIARY SYSTEM; HEPATOBILIARY SYSTEM CANCER; HUMAN; ISOMER; LIPID PEROXIDATION; LIVER; LIVER CANCER; LIVER CELL; LIVER PROTECTION; MITOCHONDRIAL MEMBRANE; MITOCHONDRION; NONHUMAN; OXIDATIVE STRESS; PINEAL BODY; PRIORITY JOURNAL; PROTECTION; GASTROINTESTINAL NEOPLASMS; METABOLISM; PHYSIOLOGY; BILIARY TRACT CANCER; BIOAVAILABILITY; ENTEROCHROMAFFIN CELL; GALLSTONE; HALF LIFE TIME; SYSTEMIC CIRCULATION;

ANTIOXIDANTS; BILIARY TRACT; GASTROINTESTINAL NEOPLASMS; HUMANS; LIVER; MELATONIN;

EID: 84906260661     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/1381612819666131119105826     Document Type: Article

References (214)

1. Lerner AB, Case JD, Takahashi Y, Lee Y, Mori W. Isolation of melatonin, the pineal gland factor that lightens melanocytes. J Am Chem Soc 1958; 80: 2587.
2. Axelrod J, Weissbach H. Enzymatic O-methylation of N-acetylserotonin to melatonin. Science 1960; 131: 1312.
3. Axelrod J, Weissbach H. Purification and properties of hydroxyindole-O-methyltransferase. J Biol Chem 1961; 236: 211-3.
4. Hoffman RA, Reiter RJ. Pineal gland: influence in gonads of male hamsters. Science 1965; 148: 1609-11.
5. Reiter RJ, Hester RJ. Interrelationships of the pineal gland, the superior cervical ganglia and the photoperiod in the regulation of the endocrine systems of hamsters. Endocrinology 1965; 79: 1168-70.
6. Reiter RJ, Blask DE, Johnson LY, Rudeen PK, Vaughan MK, Waring PJ. Melatonin inhibition of reproduction in the male hamster: its dependency on time of day of administration and on an intact and sympathetically innervated pineal gland. Neuroendocrinol-ogy 1976; 22: 107-16.
7. Tamarkin L, Westrom WK, Hamill AI, Goldman BD. Effect of melatonin on the reproductive systems of male and female hamsters: diurnal rhythm in sensitivity to melatonin. Endocrinology 1976; 99: 1534-41.
8. Barchas J, DaCosta F, Spector S. Acute pharmacology of melatonin. Nature 1967; 214: 919-20.
9. Fevre-Montange M, Van Cauter E, Refetoff S, Desir D, Tourniaire J, Copinschi G. Effects of "jet lag" on hormonal patterns. II. Adaptation of melatonin circadian periodicity. J. Clin. Endocerinol. Me-tab 1981; 52: 642-9.
10. Starr KW. Hormonal imbalance and the sarcomata. Aust NZ J Surg 1969; 39: 142-50.
11. Hamilton T. Influence of environmental light and melatonin upon mammary tumour induction. Br J Surgeries 1969; 56: 764-6.
12. Lobo RA, Limaos EA. Inflammatory response modulated by pin-ealectomy: effect of light. Braz J Med Biol Rev 1991; 24: 1159-62.
13. Tan DX, Chen LD, Poeggeler B, Manchester LC, Reiter RJ. Mela-tonin: a potent, endogenous hydroxyl radical scavenger. Endocr J 1993, 1: 57-60.
14. Barlow-Walden LR, Reiter RJ, Abe M, et al. Melatonin stimulates brain glutathione peroxidase activity. Neurochem Int 1995, 26: 497-502.
15. Pablos MI, Agapito MT, Gutierrez R, et al. Melatonin stimulates the activity of the detoxifying enzymes glutathione peroxidase in several tissues of chicks. J Pineal Res 1995, 19: 111-5.
16. Gitto E, Reiter RJ, Karbownik M, et al. Causes of oxidative stress in the pre- and perinatal period. Neonatology 2002; 81: 146-57.
17. Reiter RJ, Tan DX, Burkhardt S. Reactive oxygen and nitrogen species and cellular and organismal decline: amelioration with melatonin. Mech. Ageing Dev 2002; 123: 1007-19.
18. Hardeland R. Antioxidative protection by melatonin: multiplicity of mechanisms from radical detoxification to radical avoidance. Endocrine 2005; 27: 119-30.
19. Tengattini S, Reiter RJ, Tan DX, Terron MP, Rodella LF, Rezzani R. Cardiovascular diseases: protective actions of melatonin. J Pineal Res 2008; 44: 16-25.
20. Maldonado MS, Murillo-Cabezas F, Terron MP, et al. The potential of melatonin in reducing morbidity-mortality after cerebrospi-nal trauma. J Pineal Res 2007; 42: 1-11.
21. Cardinali DP, Srinivasan V, Brzezinski A, Brown GM. Melatonin and its analogues in insomnia and depression. J Pineal Res 2012; 52: 365-75.
22. Hardeland R. Melatonin in aging and disease - multiple consequences of reduced secretion, options and limits of treatment. Aging Dis 2012; 3: 194-226.
23. Mauriz JL, Collardo PS, Veneroso C, Reiter RJ, Gonzales-Gallego J. A review of the molecular aspects of melatonin's anti-inflammatory actions: recent insights and recent perspectives. J Pineal Res 2013; 54: 1-14.
24. Galano A, Tan DX, Reiter RJ. On the free radical scavenging activity of melatonin's metabolites, AFMK and AMK. J Pineal Res 2013; 54: 245-57.
25. Quay WB. Retinal and pineal hydroxyindole-O-methyltransferase activity in vertebrates. Life Sci 1965, 4: 983-91.
26. Cardinali DP, Rosner JM. Retinal localization of hydroxyindole-O-methyltransferase (HIOMT) in the rat. Endocrinology 1971, 89: 301-3.
27. Bubenik GA, Brown GM, Uhlir I, Grota LJ. Immunocytochemical localization of N-acetylindole-alkylamines in the pineal gland, retina and cerebellum. Brain Res 1974, 81: 233-42.
28. Abe M, Itoh MT, Miyata M, Shimiza K, Sumi Y. Circadian rhythm of serotonin N-acetyltransferase activity in rat lens. Exp. Eye Res 2000; 70: 805-8.
29. Jimenez-Jorge S, Guerrero JM, Jimenez-Caliani AJ, et al. Evidence of melatonin synthesis in the rat brain during development. J Pineal Res 2007; 42: 240-6.
30. Slominski A, Pisarchick A, Semak I, et al. Serotoninergic and melatoninergic systems are fully expressed in human skin. FASEB J 2002; 16: 896-8.
31. Lanoix D, Lacasse AA, Reiter RJ, Vaillancourt C. Melatonin, the smart biller: the human trophoblast as a model. Mol. Cell. Endocri-nol 2012; 343: 1-11.
32. Raikhlin NT, Kvetnoy I, Tolkachev VN. Melatonin may be synthe-sised in enterochromaffin cells. Nature 1975, 255: 344-5.
33. Bubenik GA, Brown GM, Grota LJ. Immunohistological localization of melatonin in the rat digestive system. Cell. Mol. Life Sci 1977, 33: 662-3.
34. Chen CQ, Fichna J, Bashashati M, Li YY, Storr M. Distribution, function and physiological role of melatonin in the lower gut. World J. Gastroenterol 2011; 17: 3888-98.
35. Han Y, DeMarrow S, Invernizzi P, et al. Melatonin exerts by an autocrine loop antiproliferative effects in cholangiocarcinoma: its synthesis is reduced favoring cholangiocarcinoma growth. Am. J Physiol. Gastrointest. Liver Physiol 2011; 301: G623-33.
36. Venegas C, Garcia JA, Escames G, et al. Extrapineal melatonin: analysis of its subcellular distribution and daily fluctuations. J Pineal Res 2012; 52: 217-27.
37. Tan DX, Manchester LC, Liu XY, Rosales-Corral SA, Acuna-Castroviejo D, Reiter RJ. A hypothesis related to mitochondria and chloroplasts as sites of melatonin synthesis and metabolism. J Pineal Res 2013; 54: 127-38.
38. Velarde E, Cerda-Reverter JM, Alonso-Gomez AL, Sanchez E, Isorna E, Delgado MJ. Melatonin synthesizing enzymes in pineal, retina, liver and gut of the goldfish (Carassius): mRNA expression pattern and regulation of daily rhythms by lighting conditions. Neu-rogastroenterol. Motil 2010; 27: 1178-201.
39. Reiter RJ, Tan DX. What constitutes a physiological concentration of melatonin. J. Pineal Res 2003; 34: 79-80.
40. Reiter RJ, Tan DX, Rosales-Corral S, Manchester LC. The universal nature, unequal distribution and antioxidant functions of mela-tonin and its metabolites. Mini-Rev. Med. Chem 2013; 13: 373-84.
41. Reiter RJ. Normal patterns of melatonin levels in the pineal gland and body fluids of humans and experimental animals. J Neural Transm 1986, 21(Supplement): 35-54.
42. Arendt J. Melatonin. Br. Med. J 1996; 312: 1242-3.
43. Tast A, Love RJ, Evans G, et al. The pattern of melatonin secretion is rhythmic in the domestic pig and responded rapidly to changes in daylength. J Pineal Res 2001; 31: 294-300.
44. Tan DX, Manchester LC, Reiter RJ, Qi W, Hanes MA, Farley NJ. High physiological levels of melatonin in the bile of mammals. Life Sci 1999; 65: 2523-9.
45. Skinner DC, Malpaux B. High melatonin concentrations in third ventricular cerebrospinal fluid are not due to Galen vein blood recirculating through the choroid plexus. Endocrinology 1999; 140: 4398-405.
46. Huether G, Poeggeler B, Reimer A, et al. Effect of tryptophan administration on circulating melatonin levels in chicks and rats: evidence for stimulation of melatonin synthesis and release in the gastrointestinal tract. Life Sci 1992, 51: 945-53.
47. Hedlund L, Lischko MM, Rollag MD, Niswender GD. Melatonin: daily cycle in plasma and cerebrospinal fluid of calves. Science 1977, 195: 686-7.
48. Sjoblom M, Flemstrom G. Melatonin in the duodenal lumen is a potent stimulant of mucosal bicarbonate secretion. J Pineal Res 2003; 34: 288-93.
49. Dubbels R, Reiter RJ, Klenke E, et al. Melatonin in edible plants identified by radioimmunoassay and by high performance liquid chromatography-mass spectrometry. J Pineal Res 1995, 18: 28-31.
50. Hattori A, Migitaka H, Iigo M, et al. Identification of melatonin in plants and its effects in plasma melatonin levels and binding to melatonin receptors in vertebrates. Biochem. Mol. Biol. Int 1995, 35: 627-34.
51. Manchester LC, Tan DX, Reiter RJ, Park W, Monis K, Qi W. High levels of melatonin in the seeds of edible plants: possible function in germ tissue protection. Life Sci 2000; 67: 3023-9.
52. Okazaki M, Higuchi K, Hanawa Y, Shiraiwa Y, Ezura H. Cloning and characterization of a Chlamydomonas reinhardtii cDNA ary-lalkylamine N-acetyltransferase and its use in the genetic engineering of melatonin content in the Micro-Tom tomato. J Pineal Res 2009; 46: 373-82.
53. Kang K, Lee K, Park S, Byeon Y, Back K. Molecular cloning of rice serotonin N-acetyltransferase, the penultimate gene in plant melatonin biosynthesis. J Pineal Res 2013; 55: 7-13.
54. Mercolini L, Mandrioli R, Raggi MA. Content of melatonin and other antioxidants in grape-related foodstuffs: measurement using a MEPS-HPLC-F method. J Pineal Res 2012; 53: 21-8.
55. Sea-Teaw M, Johns, J, Pratheepawanit Johns N, Subongkot S. Serum melatonin levels and antioxidant capacities after consumption of pineapple, orange, or banana by healthy male volunteers. J Pineal Res 2013; 55: 58-64.
56. Vitalini S, Gardana C, Simonetti P, Fico G, Iriti M. Melatonin, melatonin isomers and stilbenes in Italian traditional grape products and their antiradical capacity. J Pineal Res. 2013; 54: 322-33.
57. Park S, Nguyen Le TN, Byeon Y, Kim YS, Back K. Transient induction of melatonin biosynthesis in rice (Oryza sativa L.) during the reproductive stage. J Pineal Res 2013; 55: 40-5.
58. Vitalini S, Gardana C, Zanzotto A, et al. From vineyard to glass: agrochemicals enhance the melatonin and total polyphenol contents and antiradical activity of red wines. J Pineal Res 2011; 51: 278-85.
59. Gomez FJ, Raba J, Cerutti S, Silva MF. Monitoring melatonin and its isomers in Vitis vinifera cv. Malbec by UHPLC-MS/MS from grape to bottle. J Pineal Res 2012; 52: 349-55.
60. Tan DX, Hardeland R, Manchester LC, et al. Emergence of naturally occurring melatonin isomers and their proposed nomenclature. J Pineal Res 2012; 52: 113-21.
61. Ramakrishna A, Giridhar P, Sankar KU, Aswathanarayana G. Melatonin and serotonin profiles in beans of Coffea species. J Pineal Res 2012; 52: 470-6.
62. Garcia-Moreno H, Calvo JR, Maldonado MD. High levels of mela-tonin generated during the brewing process. J Pineal Res 2013; 55: 26-30.
63. Oba S, Nakamura K, Sahashi Y, Hattori A, Nagata C. Consumption of vegetables alters morning urinary 6-sulfatoxymelatonin concentration. J Pineal Res 2008; 45: 17-23.
64. Reiter RJ, Manchester LC, Tan DX. Melatonin in walnuts: influence on levels of melatonin and total antioxidant activity of the blood. Nutrition 2005; 21: 920-4.
65. Garrido M, Paredes SD, Cubero J, et al. Jerte Valley cherry-enriched diets improve nocturnal rest and increase 6-sulfatoxymelatonin and total antioxidant capacity in the urine of middle-aged and elderly men. J Gerontol. A Biol. Sci. Med. Sci 2010; 65: 909-14.
66. Manchester LC, Poeggeler B, Alvares FL, Ogden GB, Reiter RJ. Melatonin immunoreactivity in the photosynthetic prokaryote Rhodospirillum rubrum: implications for an ancient antioxidant system. Cell. Mol. Biol. Res 1995, 41: 391-5.
67. Renzi A, Glaser S, DeMarrow S, et al. Melatonin inhibits cholan-giocyte hyperplasia in cholestatic rats by interaction with MT1 but not MT2 melatonin receptors. Am. J Physiol. Gastrointest. Liver Physiol 2011; 301: G634-43.
68. Boquillon M, Paris R, Clement J. The effect of various dietary factors on the size distribution of lymph fat particles in rat. Lipids 1977, 12: 500-4.
69. Bjorneboe A, Bjorneboe GE, Drevon CA. Absorption, transport and deposition of vitamin E. J Nutr 1990, 120: 233-42.
70. Sheehe DM, Green JB, Green MH. Influence of dietary fat saturation on lipid absorption in the rat. Atherosclerosis 1980, 37: 301-10.
71. Stasica P, Ulanski P, Rosiak JM. Melatonin as a hydroxyl radical scavenger. J. Pineal Res 1998; 25: 65-6.
72. Mahal HS, Sharma HS, Mukherjee T. Antioxidant properties of melatonin: a pulse radiolysis study. Free Rad. Biol. Med 1999; 26: 557-65.
73. Bromme HJ, Morke W, Peschke D, Ebelt H, Peschke E. Scavenging effect of melatonin on hydroxyl radicals generated by alloxan. J Pineal Res 2000; 29: 201-8.
74. Peyrot F, Ducrocq C. Potential role of tryptophan derivatives in stress responses characterized by the generation of reactive oxygen and nitrogen species. J Pineal Res 2008; 45: 235-46.
75. Velkov ZA, Velkov YZh, Galunska BT, Paskalev DN, Tadjer AV. Melatonin: quantum-chemical and biochemical investigation of antioxidant activity. Eur. J Med. Chem 2009; 44: 2834-9.
76. Galano A. On the direct scavenging activity of melatonin towards hydroxyl and a series of peroxyl radicals. Phys. Chem. Chem. Phys 2011; 13: 7178-88.
77. Galano A, Tan DX, Reiter RJ. Melatonin as a natural ally against oxidative stress: a physiochemical examination. J Pineal Res 2011; 51: 1-16.
78. Mukherjee D, Ghosh AK, Bandyopadhyay A, et al. Melatonin protects against isoproterenol-induced alterations in cardiac mitochondrial energy-metabolizing enzymes, apoptotic proteins, and assists in complete recovery from myocardial injury in rats. J Pineal Res 2012; 53: 166-79.
79. Tan DX, Manchester LC, Reiter RJ, et al. Melatonin directly scavenges hydrogen peroxide: a potentially new metabolic pathway of melatonin biotransformation. Free Rad. Biol. Med 2000; 29: 177-85.
80. Bagchi M, Balmoori J, Ye X, Bagchi D, Ray SD, Stohs S. Protective effect of melatonin on naphthalene-induced oxidative stress and DNA damage in cultured macrophage J774A.1 cells. Mol. Cell. Biochem 2001; 22: 49-55.
81. Hardeland R, Pandi-Perumal SR. Melatonin, a potent agent in antioxidative defense: actions as a natural food constituent, gastrointestinal factor, drug and prodrug. Nutr. Metab 2005; 2: 22-37.
82. Haramimowicz J, Marques KL, Silva AF, et al. Chemiluminomet-ric evaluation of melatonin and selected melatonin precursors' interaction with reactive oxygen and nitrogen species. Anal. Biochem 2012; 420: 1-6.
83. Gilad E, Cuzzocrea S, Zingarelli B, Salzman AL, Szabo C. Melatonin as a scavenger of peroxynitrite. Life Sci 1997; 60: PL169-PL174.
84. Noda Y, Mori A, Liburdy R, Packer L. Melatonin and its precursors scavenge nitric oxide. J Pineal Res 1999; 27: 159-63.
85. Zhang H, Squadrito GL, Pryor WA. The reaction of melatonin in peroxynitrite: formation of melatonin radical anion and absence of stable nitrated products. Biochem. Biophys. Res. Commun 1998; 251: 283-7.
86. Zhang H, Squadrito GL, Uppu R, Pryor WA. Reaction of peroxynitrite with melatonin: a mechanistic study. Chem. Res. Toxicol 1999; 12: 526-34.
87. Stankov B, Reiter RJ. Melatonin receptors: current status, facts, and hypotheses. Life Sci 1990, 46: 971-82.
88. Acuna-Castroviejo D, Reiter RJ, Menendez-Pelaez A, Pablos MI, Burgos A. Characterization of high-affinity melatonin binding sites in purified cell nuclei of rat liver. J. Pineal Res 1994, 16: 100-12.
89. Dubocovich ML, Markowska M. Functional MT1 and MT2 melatonin receptors in mammals. Endocrine 2005; 27: 101-10.
90. Carrillo-Vico A, Guerrero JM, Lardone PJ, et al. A review of the multiple actions of melatonin on the immune system. Endocrine 2005; 27: 189-200.
91. Slominski RM, Reiter RJ, Schlobritz-Loutseritch N, Ostrom RS, Slominski AT. Melatonin membrane receptors in peripheral tissues: distribution and functions. Mol. Cell. Endocrinol 2012; 351: 152-66.
92. Pablos MI, Reiter RJ, Ortiz GG, et al. Rhythms of glutathione peroxidase and glutathione reductase in brain of chick and their inhibition by light. Neurochem. Int 1998; 32: 69-75.
93. Reiter RJ, Tan DX, Osuna C, Gitto E. Actions of melatonin in the reduction of oxidative stress: a review. J Biomed. Sci 2000; 7: 444-58.
94. Rodriguez C, Mayo JC, Sainz RM, et al. Regulation of antioxidant enzymes: a significant role for melatonin. J Pineal Res 2004; 36: 1-9.
95. Urat Y, Honma S, Goto S, et al. Melatonin induces y-glutamylcysteine synthetase mediated by activator protein-1 in human vascular endothelial cells. Free Radic. Biol. Med 1999; 27: 838-47.
96. Tan DX, Manchester LC, Reiter RJ, Qi W, Karbownik M, Calvo JR. Significance of melatonin in antioxidative defense system: reactions and products. Biol. Signals Rec 2000; 9: 137-59.
97. Tan DX, Manchester LC, Terron MP, Flores LJ, Reiter RJ. One molecule, many derivatives: a never-ending interaction of mela-tonin with reactive oxygen and nitrogen species? J. Pineal Res 2007; 42: 28-42.
98. Hardeland R, Tan DX, Reiter RJ. Kynuramines, metabolites of melatonin and other indoles: the resurrection of an almost forgotten class of biogenic amines. J Pineal Res 2009; 47: 109-26.
99. Burkhardt S, Reiter RJ, Tan DX, Hardeland R, Cabrera J, Kar-bownik M. DNA oxidatively damaged by chromium (III) and H2O2 is protected by the antioxidants melatonin, N1-acetyl-N2-formyl-5-methoxykynuramine, resveratrol and uric acid. Int J. Biochem. Cell. Biol 2001; 33: 775-83.
100. Ressmeyer AR, Mayo JC, Zelosko V, et al. Antioxidant properties of the melatonin metabolite N1-acetyl-5-methoxykynuramine (AMK): scavenging of free radicals and prevention of protein destruction. Redox. Rep 2003; 8: 208-13.
101. Tan DX, Manchester LC, Burkhardt S, et al. N1-acetyl-N2-formyl-5-methoxykynuramine, a biogenic amine and melatonin metabolite, functions as a potent antioxidant. FASEB J 2001; 15: 2294-6.
102. Schaefer M, Hardeland R. The melatonin metabolite N-acetyl-5-methoxykynuramine is a potent singlet oxygen scavenger. J Pineal Res 2009; 48: 49-52.
103. Guenther AL, Schmidt SI, Laatsch H, et al. Reactions of melatonin metabolite AMK (N1-acetyl-5-methoxykynuramine) with reactive nitrogen species: formation of novel compounds, 3-acetomidomethyl-6-methoxycinnolinone and 3-nitro-AMK. J Pineal Res 2005; 39: 251-260.
104. Tan DX, Hardeland R, Manchester LC, et al. Mechanistic and comparative studies of melatonin and classic antioxidants in terms of their interactions with the ABTS cation radical. J. Pineal Res 2003; 34: 249-59.
105. Hardeland R, Pandi-Perumal SR. Melatonin, a potent agent in antioxidative defense: action as a natural food constituent, gastrointestinal factor, drug and prodrug. Nutr. Metab 2005; 2: 22-45.
106. Molina-Carballo A, Munoz-Hoyos A, Reiter RJ, Sanchez-Forte M, Moreno F. Utility of high doses of melatonin as adjunctive anti-convulsant therapy in a child with severe myoclonic epilepsy: two years' experience. J Pineal Res 1997; 23: 97-105.
107. Tan DX, Manchester LC, Reiter RJ, Qi W, Kim SJ, El-Sokkary GH. Ischemia/reperfusion-induced arrhythmias in the isolated rat heart: prevention by melatonin. J. Pineal Res 1998; 25: 184-91.
108. Maldonado MD, Murrillo-Cabezos F, Terron MP, et al. The potential role of melatonin in reducing morbidity-mortality after cranio-cerebral trauma. J Pineal Res 2007; 42: 1-11.
109. Abe M, Reiter RJ, Orhii PB, Hara H, Poeggeler B. Inhibitory effect of melatonin on cataract formation in newborn rats: evidence for an antioxidative role for melatonin. J Pineal Res 1994, 17: 94-100.
110. Reiter RJ. The pineal gland and melatonin in relation to aging: a summary of the theories and of the data. Exp. Gerontol 1995, 30: 199-212.
111. Reiter RJ, Tan DX, Kim SJ, et al. Augmentation of indices of oxi-dative damage in life-long melatonin-deficient rats. Mech. Ageing Dev 1999; 110: 157-73.
112. Benot S, Goberna R, Reiter RJ, Garcia-Maurino S, Osuna C, Guerrero, JM. Physiological levels of melatonin contribute to the anti-oxidant capacity of human serum. J. Pineal Res 1999; 27: 59-64.
113. Koppisetti S, Jenigiri B, Terron MP, et al. Reactive oxygen species and the hypomotility of the gall bladder as targets for the treatment of gallstones with melatonin: a review. Dig. Dis. Sci 2008; 53: 2592-603.
114. Pozo MJ, Gomez-Pinilla PJ, Camello-Almaraz C, et al. Melatonin, a potential therapeutic agent for smooth muscle-related pathological conditions and aging. Curr. Med. Chem 2010; 17: 4150-65.
115. Shiesh SC, Chen CY, Lin XZ, Liu ZA, Tsao HC. Melatonin prevents pigment gallstone formation induced by bile duct ligation in guinea pigs. Hepatology 2000; 32: 455-60.
116. Halliwell B, Gutteridge JMC, Cross CE. Free radicals, antioxidants and human diseases: where are we now? J. Clin. Lab. Med 1992, 119: 598-620.
117. Al-Muqbel KM. Gallbladder ejection fraction measured by fatty meal cholescintigraphy: is it affected by extended gallbladder emptying data acquisition time? Ann. Nucl. Med 2010; 24: 29-34.
118. Ham M, Kaunitz JD. Gastroduodenal defense. Curr. Opin. Gastrointestinal 2007; 23: 607-16.
119. Celinski K, Konturek PC, Konturek SJ, et al. Effect of melatonin and tryptophan on healing of gastric and duodenal ulcers with Heli-cobacter pylori infection in humans. J Pharm. Pharmacol 2011; 62: 521-6.
120. Jaworek J, Nawrot K, Konturek SJ, Leja-Szpak A, Thor P, Pawlik WW. Melatonin and its precursor, L-tryptophan: influence on pancreatic amylase secretion in vivo and in vitro. J. Pineal Res 2004; 36: 155-64.
121. Nawrot-Porabka K, Jaworek J, Leja-Szpak A, Szklarczyk J, Kon-turek SJ, Reiter RJ. Luminal melatonin stimulates pancreatic enzyme secretion via activation of serotonin-dependent nerves. Pharmacol. Rep 2013; 65: 494-504.
122. Anderson JM, Van Itallie CM. Tight junctions and the molecular basis for regulation of paracellular permeability. Am. J Physiol 1995, 269: G467-75.
123. Schwarz B, Salak N, Hofstotter H, et al. Intestinal ischemia reper-fusion syndrome: pathophysiology, clinical significance and therapy. Wien Klin. Wochenschr 1999; 111: 539-48.
124. Liu Z, Li N, Neu J. Tight junctions, leaky intestines, and pediatric diseases. Acta. Paediatr 2005; 94: 386-93.
125. Rapin JR, Weirnsperger N. Possible links between intestinal permeability and food processing: a potential therapeutic niche for glutamine. Clinics 2010; 65: 635-43.
126. Sommansson A, Nylander O, Sjoblom M. Melatonin decreases duodenal epithelial paracellular permeability via a nicotinic receptor-dependent pathway in rats in vivo. J Pineal Res 2013; 54: 282-91.
127. Chojnacki C, Wisniewska-Jarosinska M, Walecka-Kapica E, Klu-pinska G, Jaworek J, Chojnacki J. Evaluation of melatonin effectiveness in the adjuvant treatment of ulcerative colitis. J Physiol. Pharmacol 2011; 62: 327-34.
128. O'Hara AM, Shanahan F. The gut flora as a forgotten organ. EMBO Rep 2006; 7: 688-93.
129. Guarner F, Malagelada JR. Gut flora in health and disease. Lancet 2003; 361: 512-19.
130. Poeggeler B, Balzer I, Hardeland R, Lerchl A. Pineal hormone melatonin oscillates also in the dinoflagellate Gonyaulax polyedra. Naturwissenschaften 1991, 78: 268-9.
131. Sprenger J, Hardeland R, Fuhrberg B, et al. Melatonin and other 5-methoxylated indoles in yeast: presence in high concentrations and dependence on tryptophan availability. Cytologia 1999; 64: 209-13.
132. Clemente JC, Ursell LK, Parfrey LW, Knight R. The impact of the gut microbiota on human health: an integrative view. Cell 2012; 148: 1258-70.
133. Macfarlane GT, Macfarlane S. Bacteria, colonic fermentation and gastrointestinal health. J AOAC Int 2012; 95: 39-49.
134. Rodriguez-Naranjo MI, Gil-Izquierdo A, Troncoso AM, Cantos E, Garcia-Parrilla MC. Melatonin: a new bioactive compound in wine. J Food Compos. Anat 2011; 24: 603-8.
135. Tarzia G, Diamantini G, di Giacomo B, et al. 1-(2-Alkanamidoethyl)-6-methoxyindole derivatives: a new class of potent indole melatonin analogues. J Med. Chem 1997; 40: 2003-10.
136. Spadoni G, Diamantini G, Bedini A, et al. Synthesis, antioxidant activity and structure activity relationships for a new series of 2-(N-acylaminoethyl)indoles with melatonin-like cytoprotective activity. J Pineal Res 2006; 40: 259-69.
137. Konturek PC, Brzozowski T, Konturek SJ. Stress and the gut: pathophysiology, clinical consequences, diagnostic approach and treatment options. J Physiol. Pharmacol 2011; 62: 591-9.
138. Nanau RM, Neuman MG. Metabolome and inflammasome in inflammatory bowel disease. Transpl Res 2012; 160: 1-28.
139. Pearson C, Uhlig HH, Powrie F. Lymphoid microenvironments and innate lymphoid cells in the gut. Trends Immunol 2012; 33: 289-96.
140. Wu HJ, Wu E. The role of gut microbiota in immune homeostasis and autoimmunity. Gut Microbes 2012; 3: 4-14.
141. Laliena A, San Miguel B, Crespo I, Alvarez M, Gonzalez-Gallego J, Tunon MJ. Melatonin attenuates inflammation and promotes regeneration in rabbits with fulminant hepatitis of viral origin. J Pineal Res 2012; 53: 270-8.
142. Turrens JF, Boveris A. Generation of superoxide anion by the NADH dehydrogenase of bovine heart mitochondria. Biochem. J 1980, 191: 421-7.
143. Olanow CW. A radical hypothesis for neurodegeneration. Trends Neurosci 1993, 16: 439-44.
144. Sewerynek E, Reiter RJ, Melchiorri D, Ortiz GG, Lewinski A. Oxidative damage in the liver induced by ischemia/reperfusion: protection by melatonin. Hepatogastroenterology 1995, 43: 898-903.
145. Mathes AM. Hepatoprotective actions of melatonin: possible mediation by melatonin receptors. World J. Gastroenterol 2010; 16: 6087-97.
146. Cho EH, Koh PO. Proteomic identification of proteins differentially expressed by melatonin in hepatic ischemia-reperfusion injury. J Pineal Res 2010; 49: 349-55.
147. Kang JW, Koh EJ, Lee SM. Melatonin protects liver against ischemia and reperfusion injury through inhibition of toll-like receptor signaling pathway. J Pineal Res 2011; 50: 403-11.
148. Koh PO. Melatonin prevents hepatic injury-induced decrease in Akt downstream targets phosphorylations. J Pineal Res 2011; 51: 214-9.
149. Kireev RA, Cuesta S, Ibarrola C, et al. Age-related differences in hepatic ischemia/reperfusion: gene activation, liver injury and protective effect of melatonin. J Surg. Res 2012; 178: 922-34.
150. Vairetti M, Ferrigno A, Baronte R, et al. Exogenous melatonin enhances bile flow and ATP levels after cold storage and perfusion in rat liver: implications for liver transplantation. J Pineal Res 2005; 38: 223-30.
151. von Heesen H, Seibert K, Halsere M, et al. Multidrug donor preconditioning protects steatotic liver grafts against ischemia-reperfusion injury. Am. J Surg 2012; 203: 168-72.
152. Zaouali A, Reiter RJ, Padrissa-Altes S, et al. Melatonin protects steatotic and nonsteatotic liver grafts against cold ischemia and reperfusion injury. J Pineal Res 2011; 50: 213-21.
153. Brent JA, Rumack BH. Role of free radicals in toxic hepatic injury. II. Are free radicals the cause of toxin-induced liver injury? J. Toxicol. Clin. Toxicol 1993, 31: 173-96.
154. Daniels WMU, Reiter RJ, Melchiorri D, Sewerynek E, Pablose MI, Ortiz GG. Melatonin counteracts lipid peroxidation induced by carbon tetrachloride but does not restore glucose-6-phosphatase activity. J Pineal Res 1995, 19: 1-6.
155. Hong RT, Xu JM, Mei Q. Melatonin ameliorates experimental hepatic fibrosis induced by carbon tetrachloride in rats. World J. Gastroenterol 2009; 15: 1452-8.
156. Wang H, Wei W, Wang NP, et al. Melatonin ameliorates carbon tetrachloride-induced hepatic fibrogenesis in rats via inhibition of oxidative stress. Life Sci 2005; 77: 1902-15.
157. Ogeturk M, Kus I, Pekmez H, Yekeler H, Sahin S, Sarsilmaz M. Inhibition of carbon tetrachloride-mediated apoptosis and oxidative stress by melatonin in experimental liver fibrosis. Toxicol. Ind. Health 2008; 24: 201-8.
158. Aranda M, Albendea CD, Lostale F, et al. In vivo hepatic oxidative stress because of carbon tetrachloride toxicity: protection by mela-tonin and pinoline. J Pineal Res 2010; 49: 78-85.
159. Cheshchevik VT, Lapshina EA, Dremza IK, et al. Rat liver mito-chondrial damage under acute and chronic carbon tetrachloride-induced intoxication: protection by melatonin and cranberry fla-vonoids. Toxicol. Appl. Pharmacol 2012; 261: 271-9.
160. Rapozzi V, Comelli M, Mavelli I, et al. Melatonin and oxidative damage in mice liver induced by the prooxidant antitumor drug, adriamycin. In Vivo 1999; 13: 45-50.
161. Matsura T, Nishida T, Togawa A, et al. Mechanisms of protection by melatonin against acetaminophen-induced liver injury. J Pineal Res 2006; 41: 211-8.
162. Oz E, Ilhan MN. Effects of melatonin in reducing the toxic effects of doxorubicin. Mol. Cell. Biochem 2006; 286: 11-5.
163. Catala A, Zvara A, Puskas LG, Kitajka K. Melatonin-induced gene expression changes and its preventive effects on adriamycin-induced lipid peroxidation in rat liver. J Pineal Res 2007; 42: 43-9.
164. Laothong U, Pinlaor P, Hiraku Y, et al. Protective effect of mela-tonin against Opisthorchis viverrini-induced oxidative and nitrosa-tive DNA damage and liver injury in hamsters. J Pineal Res 2010; 49: 271-82.
165. Tunon MJ, San Miguel B, Crespo I, et al. Melatonin attenuates apoptotic liver damage in fulminant hepatic failure induced by the rabbit hemorrhagic disease virus. J Pineal Res 2011; 50: 38-45.
166. Hsu JT, Kuo CJ, Chen TH, et al. Melatonin prevents hemorrhagic shock-induced liver injury in rats through an Akt-dependent HO-1 pathway. J Pineal Res 2012; 53: 410-6.
167. Harman D. Aging: a theory based on free radical and radiation chemistry. J Gerontol 1956, 11: 298-300.
168. Reiter RJ, Richardson BA, Johnson LY, Ferguson BN, Dink DT. Pineal melatonin rhythm: reduction in aging Syrian hamster. Science 1980, 210: 1372-73.
169. Reiter RJ, Craft CM, Johnson Jr JE, et al. Age-associated reduction in nocturnal pineal melatonin levels in female rats. Endocrinology 1981, 109: 1295-7.
170. Castillo C, Salazar V, Ariznavarreta C, Vara E, Tresguerres JA. Effect of melatonin administration on parameters related to oxida-tive damage in hepatocytes isolated from old Wistar rats. J Pineal Res 2005; 38: 240-6.
171. Sanchez-Hidalgo M, de la Lastra CA, Carrascosa-Salmoral MP, et al. Age-related changes in melatonin synthesis in rat extrapineal tissues. Exp. Gerontol 2009; 44:328-34.
172. Mauriz JL, Molpeceres V, Garcia-Mediavilla MV, Gonzalez P, Barrio JP, Gonzalez-Gallego J. Melatonin prevents oxidative stress and changes in antioxidant enzyme expression and activity in the liver of aging rats. J Pineal Res 2007; 42: 222-30.
173. Okatani Y, Wakasuki A, Reiter RJ. Melatonin protects hepatic mitochondrial respiratory chain activity in senescence-accelerated mice. J Pineal Res 2002; 32: 143-8.
174. Okatani Y, Wakatsuki A, Reiter RJ, Miyahara Y. Acutely administered melatonin restores hepatic mitochondrial physiology in old mice. Int. J Biochem. Cell Biol 2003; 35: 367-75.
175. Escames G, Lopez LC, Ortiz F, Ros E, Acuna-Castroviego D. Age-dependent lipopolysaccharide-induced iNOS expression and multiorgan failure in rats: effects of melatonin treatment. Exp. Ger-ontol 2006; 41: 1165-73.
176. Kireev RA, Tresguerres, AC, Garcia C, Ariznavarreta C, Vara E, Tresguerres JA. Melatonin is able to prevent the liver of old castrated female rats from oxidative and pro-inflammatory damage. J Pineal Res 2008; 45: 394-402.
177. Cuesta S, Kireev R, Forman K, et al. Melatonin improves inflammation processes in liver of senescence-accelerated prone male mice (SAMP8). Exp. Gerontol 2010; 45: 950-6.
178. Reiter RJ, Tan DX, Sainz RM, Mayo JC. Melatonin: reducing the toxicity and increasing the efficacy of drugs. J Pharm. Pharmacol. 2002; 54: 1299-321.
179. Escames G, Acuna-Castroviejo D, Lopez LC, et al. The pharmacological utility of melatonin in the treatment of septic shock: experimental and clinical evidence. J Pharm. Pharmacol 2006; 58: 1158-65.
180. Mills E, Wu P, Seely D, Guyatt G. Melatonin in the treatment of cancer: a systemic review of randomized controlled-trials and meta-analysis. J Pineal Res 2005; 31: 360-6.
181. Dziegel P, Podhorska-Okolow M, Zabel M. Melatonin: adjuvant therapy of malignant tumors. Med. Sci. Monit 2008; 14: RA64-RA70.
182. Benitez-King G, Soto-Vega E, Ramirez-Rodriguez G. Melatonin modulates microfilament phenotypes in epithelial cells: implications for adhesion and inhibition of cancer cell migration. Histol. Histopathol 2009; 27: 789-99.
183. Jung-Hynes B, Reiter RJ, Ahmad N. Sirtuins, melatonin and cir-cadian rhythms: building a bridge between aging and cancer. J Pineal Res 2010; 48: 9-19.
184. Blask DE, Hill DE, Dauchy RT, et al. Circadian regulation of molecular, dietary, and metabolic signaling mechanisms of human breast cancer growth by the nocturnal melatonin signal and the consequences of its disruption by light at night. J Pineal Res 2011; 51: 259-69.
185. Lissoni P, Rovelli F. Principles of psychoneuroendocrinoimmuno-therapy of cancer. Immunotherapy 2012; 4: 77-86.
186. Reiter RJ. Mechanisms of cancer inhibition by melatonin. J Pineal Res 2004; 37: 213-4.
187. Blask DE, Dauchy RT, Sauer LA. Putting cancer to sleep at night: the neuroendocrine/circadian melatonin signal. Endocrine 2005; 27: 179-89.
188. Erren TC, Reiter RJ. A generalized theory of chronodisruption and cancer. Neuroendocrinol. Lett 2008; 29: 815-21.
189. Hill SM, Frasch T, Xiang S, Yuan L, Duplessis T, Mao L. Molecular mechanisms of melatonin's anticancer effects. Integr. Cancer Ther 2009; 8: 337-46.
190. Korkmaz A. Sanchez-Barcelo EJ, Tan DX, Reiter RJ. Role of melatonin in the epigenetic regulation of breast cancer. Breast Cancer Res. Treat 2009; 115: 13-27.
191. Mediavilla MD, Sanchez-Barcelo EJ, Tan DX, Manchester LC, Reiter RJ. Basic mechanisms involved in the anti-cancer effects of melatonin. Curr. Med. Chem 2010; 17: 4462-81.
192. Alvarez-Garcia V, Gonzalez A, Alonso-Gonzalez C, Martinez-Campa C, Cos S. Melatonin interferes in the desmoplastic reaction in breast cancer by regulating cytokine production. J Pineal Res 2012; 52: 282-90.
193. Cui P, Yu M, Peng X, Dong L, Yang Z. Melatonin prevents human pancreatic carcinoma cell PANC-1-induced human umbilical vein endothelial cell proliferation and migration by inhibiting vascular endothelial growth factor express. J Pineal Res 2012; 52: 236-43.
194. Proietti S, Cucina A, Reiter RJ, Bizzari M. Molecular mechanisms of melatonin's inhibitory actions on breast cancers. Cell. Mol. Life Sci. 2013; 70: 2139-2157.
195. Sanchez-Hidalgo M, Lee M, de la Lastra CA, Guerrero JM, Pack-ham G. Melatonin inhibits cell proliferation and induces caspase activation and apoptosis in human malignant lymphoid cell lines. J Pineal Res 2012; 53: 366-73.
196. Ugur AC, Cig B, Espino J, et al. Melatonin potentiates chemotherapy-induced cytotoxicity and apoptosis in rat pancreatic tumor cells. J Pineal Res 2012; 53: 91-8.
197. Min KJ, Kim HS, Park EJ, Kwon PK. Melatonin enhances thapsi-garin-induced apoptosis through reactive oxygen species-mediated upregulation of CCAAT-enhancer-binding protein in homologous protein human renal cancer cells. J Pineal Res 2012; 53: 99-106.
198. Zha L, Fan L, Sun G, et al. Melatonin sensitizes human hepatoma cells to endoplasmic reticulum stress-induced apoptosis. J Pineal Res 2012; 52: 322-31.
199. Sainz RM, Mayo JC, Rodriguez C, Tan DX, Lopez-Burillo S, Reiter RJ. Melatonin and cell death: differential actions in normal and cancer cells. Cell Mol Life Sci 2003; 60: 1407-26.
200. Jou MJ, Peng TI, Yu PZ, et al. Melatonin protects against common deletion of mitochondrial DNA-augmented mitochondrial oxidative stress and apoptosis. J Pineal Res 2007; 43: 389-403.
201. Fu Y, Tang M, Fan Y, Zou H, Sun X, Xu X. Anti-apoptotic effects of melatonin in retinal pigment epithelial cells. Front Biosci 2012; 17: 1461-8.
202. Kilic U, Yilmaz B, Ugur M, et al. Evidence that membrane-bound G protein-coupled melatonin receptors MT1 and MT2 are not involved in the neuroprotective effects of melatonin in focal cerebral ischemia. J Pineal Res 2012; 52: 228-35.
203. Zhang K, Lu Z, Jia X, Huang D. Melatonin prevents testicular damage in hyperlipidaemic rats. Andrologia 2012; 44: 230-6.
204. Wang J, Hao H, Yao L, et al. Melatonin suppresses migration and invasion via inhibition of oxidative stress pathway in glioma cells. J Pineal Res 2012; 53: 180-7.
205. Wise C, Pilanthananond M, Perry BE, Alpini G, McNeal M, Glaser SS. Mechanisms of biliary carcinogenesis and growth. World J Gastroenterol 2008; 14: 2986-9.
206. Blask DE, Dauchy RT, Sauer LA, Krause JA. Melatonin uptake and growth prevention in rat hepatoma 7288CTC in response to dietary melatonin: melatonin receptor-mediated inhibition of tumor linoleic acid metabolism to the growth signaling molecule 13-hydroxyoctadecadienoic acid and the potential role of phytomela-tonin. Carcinogenesis 2004; 25: 951-60.
207. Martin-Renedo J, Mauriz JL, Jorquera F, Ruiz-Andres O, Gonzalez P, Gonzalez-Gallego J. Melatonin induces cell cycle arrest and apoptosis in hepatocarcinoma HepG2 cell line. J Pineal Res 2008; 45: 532-40.
208. Fan LL, Sun GP, Wei W, et al. Melatonin and doxorubicin syner-gistically induce cell apoptosis in human hepatoma cell lines. World J Gastroenterol 2010; 16: 1473-81.
209. Lin ZY, Chuang WL. Pharmacological concentrations of melatonin have diverse influence on differential expressions of angiogenic chemokine genes in different hepatocellular carcinoma cell lines. Biomed Pharmacother 2010; 64: 659-62.
210. Carbajo-Pescador S, Garcia-Palomo A, Martin-Renedo J, et al. Melatonin modulation of intracellular signaling pathways in hepa-tocarcinoma HepG2 cell line: role of the MT1 receptor. J Pineal Res 2011; 51: 463-71.
211. Loeppky RN. A mechanism of bioactivation of N-nitrosodiethanolamine. Drug Metab Rev 1999; 31: 175-93.
212. Subramanian P, Mirunalini S, Dakshayani KB, Pandi-Perumal SR, Trakht I, Cardinali DP. Prevention by melatonin of hepatocarcino-genesis in rats injected with N-nitrosodiethylamine. J Pineal Res 2007; 43: 305-12.
213. Cini G, Coronnello M, Mini E, Neri B. Melatonin's growth inhibitory effect on hepatoma AH 130 in the rat. Cancer Lett 1998; 125: 51-9.
214. Yan JJ, Shen F, Wang K, Wu MC. Patients with advanced primary hepatocellular carcinoma treated by melatonin and transcatheter arterial chemoembolization: a prospective study. Hepatobiliary Pan-creat Dis Int 2002; 1: 183-6.